West Virginia · 2026 Regular Session · Bill

HB 4640: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

In committee Last action February 2, 2026: On 1st reading, House Calendar

Plain-language summary

HB 4640 is a bill introduced in the West Virginia House on January 21, 2026. According to its official title, it concerns: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration. Primary sponsor: Evan Worrell (Republican). It lists 1 additional sponsor. Most recent recorded action (February 2, 2026): On 1st reading, House Calendar.

Sponsors

Primary sponsor: Evan Worrell (Republican). 1 co-sponsor.